To Get Help Now
Defective Drug Lawsuits
Click Here
 
Today's Date:

Mass Tort Involving 75 Xarelto Cases is Created in Philadelphia

A mass tort has been organized in Philadelphia surrounding the blood-thinning drug Xarelto, which has been alleged to cause uncontrollable and sometimes fatal bleeding.

Approximately 75 Xarelto cases were transferred to the Philadelphia Court of Common Pleas’ Complex Litigation Center by the court’s Judge Kevin Dougherty. The lawsuits are filed against Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals and Bayer HealthCare Pharmaceuticals, according to The Legal Intelligencer (The Legal). More Mass Tort Involving 75 Xarelto Cases is Created in Philadelphia

National Law Firm, Parker Waichman LLP, Seeks Increased Transparency and Ethics from the Pharmaceutical Industry in the New Year

In the new year, Parker Waichman LLP hopes for increased testing, safety, and efficacy in the processes and promotions used by Big Pharma so that consumers may be confident that they are receiving safe and effective medications that were ethically developed, tested, and marketed.

Parker Waichman, a national law firm that has long been an advocate for victims of defective medications is urging the pharmaceutical industry, as we approach a new year, to step up the ways in which it develops, tests, inspects, and markets medications.

In the new year, Parker Waichman is seeking increased transparency and accountability from all drug makers, with the hope that patient welfare is made the key priority and placed before drug approval activities and profits.
More National Law Firm, Parker Waichman LLP, Seeks Increased Transparency and Ethics from the Pharmaceutical Industry in the New Year

Women with Multiple Sclerosis who Have a Higher BMI are at Higher Risk for Lymphopenia, Studies Show

Researchers in Germany and Sweden have found that some female patients taking the multiple sclerosis (MS) drug Gilenya (fingolomid) may be at increased risk for lymphopenia, a condition that affects the immune system.

Lymphopenia (also known as lymphocytopenia) is a condition in which a patient has a deficiency of lymphocytes, which play a vital role in supporting immune system function. Gilenya has been known to reduce the level of circulating lymphocytes, and one of the most common side effects of the drug reported by the U.S. Food and Drug Administration (FDA) and the drug’s manufacturer, Novartis Pharma Stein AG, is infections. Lower lymphocyte numbers make the patient more susceptible to infection, according to EmaxHealth.com. More Women with Multiple Sclerosis who Have a Higher BMI are at Higher Risk for Lymphopenia, Studies Show

Beta-Blockers Linked to Premature Death in Dialysis Patients

A new study published in an upcoming issue of the Journal of the American Society of Nephrology found that dialysis patients who take beta-blockers that can be easily removed from the blood through dialysis may be at an increased risk of premature death compared with patients whose heart medications are more difficult to remove.

A group of drugs known as beta-blockers lower the risk of premature death in heart patients not on dialysis, but the medications – used to treat angina, reduce high blood pressure and control heart rhythm – increase the risk of premature death in dialysis patients. Experts say the filtering effects of dialysis remove the beta-blockers from circulation, leaving patients unable to experience their full benefit, according to MedicalXpress.com. More Beta-Blockers Linked to Premature Death in Dialysis Patients

Parents, Beware of Topical Teething Anesthetics

Topical anesthetics containing Lidocaine Viscous are popular with parents trying sooth their little ones’ teething pain, but the medications can seriously injure, even kill, young patients.

In June, the U.S. Food and Drug Administration (FDA) warned against use of the products, particularly those containing more than 2 percent Lidocaine Viscous. The FDA said that it would require a new Boxed Warning, the FDA’s strongest warning, to all packages of the numbing agents. More Parents, Beware of Topical Teething Anesthetics

Hospira Receives FDA Warning for Drug Manufacturing Violations

The Food and Drug Administration has sent a warning letter to Hospira Inc. over “significant violations” of current good manufacturing practice (CGMP). The FDA said the company has not taken adequate steps to correct the violations, which include “visible particles” in lots of a chemotherapy drug.

In an inspection conducted from February 24 to March 1, 2014 at Hospira’s manufacturing facility in Mulgrave, Australia, FDA inspectors discovered “visible particles” in an injectable drug, The Chicago Tribune reports. The company said it is considering what corrective actions it needs to take but said it intends to respond fully to the warning letter. At this time, the FDA is not restricting the production or shipment of pharmaceutical products from the Mulgrave plant, but could do so if the violations are not corrected. More Hospira Receives FDA Warning for Drug Manufacturing Violations

Billions Paid to Doctors by Drug Firms and Medical Device Makers

Records released this week under a provision of the Affordable Care Act reveal that drug makers and medical device companies paid at least $3.5 billion to doctors and teaching hospitals during the final five months of 2013.

The Physician Payments Sunshine Act, part of the 2010 health care law, requires drug makers and manufacturers of medical devices to disclose payments to physicians and teaching hospitals, The Wall Street Journal reports. The Centers for Medicare and Medicaid Services compiled the records into a database posted online on Tuesday. CMS said about 40 percent of the payment records will not identify the recipients because of data problems. More Billions Paid to Doctors by Drug Firms and Medical Device Makers

New Jersey Man Alleges Eli Lilly Testosterone Replacement Product Caused Him a Heart Attack

Drug maker Eli Lilly is facing a lawsuit filed by a New Jersey man in federal court in Newark over the company’s testosterone replacement drug Axiron.

According to the lawsuit, the patient stated that he began taking Axiron at age 54 in September 2012 and suffered a heart attack on October 3, 2012. Had the patient known that Axiron could increase users’ risk for heart attack, he would not have started taking it, the suit states. More New Jersey Man Alleges Eli Lilly Testosterone Replacement Product Caused Him a Heart Attack

Viagra Linked to Increased Risk of Skin Cancer

Use of Viagra is linked to an increased risk of a form of skin cancer, according to a study published online in April in Jama Internal Medicine.

Viagra (sildenafil) was associated with an increased risk for melanoma, the most dangerous form of skin cancer. These cancerous growths grow when unrepaired DNA damage to skin cells triggers genetic defects that lead the skin cells to multiply quickly and form malignant tumors, SkinCancer.org reported. About one person dies every hour in the U.S. due to Melanoma.   More Viagra Linked to Increased Risk of Skin Cancer

SSRI Antidepressant Drugs Linked to Reduced bone Formation and an Increased Risk of Bone Fractures

A group of antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) reduce bone formation and increase bone fracture risks, according to a new study.

Bone metabolism is affected by osseointegration so researchers took a closer look at the association between SSRIs and the risk of failures in osseointegrated dental implants, wrote HNGN.  More SSRI Antidepressant Drugs Linked to Reduced bone Formation and an Increased Risk of Bone Fractures